Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biocryst Pharma Inc (BCRX)

Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,030,750
  • Shares Outstanding, K 206,150
  • Annual Sales, $ 331,410 K
  • Annual Income, $ -226,540 K
  • 60-Month Beta 1.92
  • Price/Sales 3.04
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BCRX with:

Options Overview Details

View History
  • Implied Volatility 67.54% ( -4.07%)
  • Historical Volatility 62.08%
  • IV Percentile 59%
  • IV Rank 30.30%
  • IV High 132.06% on 02/13/24
  • IV Low 39.49% on 03/29/23
  • Put/Call Vol Ratio 0.12
  • Today's Volume 5,501
  • Volume Avg (30-Day) 2,051
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 36,795
  • Open Int (30-Day) 53,845

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.24
  • Number of Estimates 5
  • High Estimate -0.18
  • Low Estimate -0.34
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.82 +5.30%
on 03/14/24
6.04 -16.06%
on 02/27/24
-0.85 (-14.36%)
since 02/16/24
3-Month
4.82 +5.30%
on 03/14/24
7.75 -34.58%
on 01/10/24
-1.00 (-16.47%)
since 12/18/23
52-Week
4.82 +5.30%
on 03/14/24
9.06 -44.07%
on 05/03/23
-3.03 (-37.41%)
since 03/17/23

Most Recent Stories

More News
BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript

BCRX earnings call for the period ending December 31, 2023.

BCRX : 5.07 (+1.40%)
BioCryst: Q4 Earnings Snapshot

BioCryst: Q4 Earnings Snapshot

BCRX : 5.07 (+1.40%)
BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript

BCRX earnings call for the period ending September 30, 2023.

BCRX : 5.07 (+1.40%)
BioCryst: Q3 Earnings Snapshot

BioCryst: Q3 Earnings Snapshot

BCRX : 5.07 (+1.40%)
3 Magnificent Growth Stocks to Buy on the Dip

These three biotech stocks are attractive buys right now.

AGEN : 0.5297 (-1.91%)
BCRX : 5.07 (+1.40%)
NNOX : 11.38 (+5.57%)
BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript

BCRX earnings call for the period ending June 30, 2023.

BCRX : 5.07 (+1.40%)
BioCryst: Q2 Earnings Snapshot

BioCryst: Q2 Earnings Snapshot

BCRX : 5.07 (+1.40%)
BioCryst Pharmaceuticals (BCRX) Q1 2023 Earnings Call Transcript

BCRX earnings call for the period ending March 31, 2023.

BCRX : 5.07 (+1.40%)
Why BioCryst Pharmaceuticals Stock Is Soaring Today

The biotech's Q1 earnings report contained a number of positives.

BCRX : 5.07 (+1.40%)
BioCryst: Q1 Earnings Snapshot

BioCryst: Q1 Earnings Snapshot

BCRX : 5.07 (+1.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential...

See More

Key Turning Points

3rd Resistance Point 5.49
2nd Resistance Point 5.33
1st Resistance Point 5.20
Last Price 5.07
1st Support Level 4.91
2nd Support Level 4.76
3rd Support Level 4.63

See More

52-Week High 9.06
Fibonacci 61.8% 7.44
Fibonacci 50% 6.94
Fibonacci 38.2% 6.44
Last Price 5.07
52-Week Low 4.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar